BIGHAM MICHAEL (Chairman and CEO) sold 4.2% of their position (51.38K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $101.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/14/2022ACC: 0000904454-22-000621
DirectorOfficer· Chairman and CEO
Since Jul 2018
-51.38K
Net shares
Net seller
$101.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
51.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−19.48K
Price / share
$1.98
Trade value
$38.58K
% of position
1.6%
12/12/2022
1.23M→1.21M
Common Stock
Direct
Shares
−31.89K
Price / share
$1.96
Trade value
$62.51K
% of position
2.6%
12/13/2022
1.21M→1.18M
Total
Net shares
−51.38K
Net value
-$101.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2022 | S · Sale | −19.48K | $1.98 | $38.58K | 1.6% | 1.23M | 1.21M |
| Common Stock Direct | 12/13/2022 | S · Sale | −31.89K | $1.96 | $62.51K | 2.6% | 1.21M | 1.18M |
| Total | −51.38K | -$101.08K | ||||||
Derivative Transactions0
No derivative transactions reported